Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,972 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prediction of a sustained viral response in chronic hepatitis C patients who undergo induction therapy with double filtration plasmapheresis plus interferon-β/ribavirin.
Ishikawa T, Abe S, Kojima Y, Sano T, Iwanaga A, Seki KI, Honma T, Yoshida T, Yamazaki M, Sakai T, Tasaki K, Suzuki Y. Ishikawa T, et al. Among authors: sano t. Exp Ther Med. 2015 May;9(5):1646-1650. doi: 10.3892/etm.2015.2340. Epub 2015 Mar 10. Exp Ther Med. 2015. PMID: 26136872 Free PMC article.
Telaprevir-based triple therapy following partial splenic arterial embolization for chronic hepatitis C with thrombocytopenia can reduce carcinogenesis and improve hepatic function reserve.
Ishikawa T, Abe S, Kojima Y, Horigome R, Sano T, Iwanaga A, Seki K, Honma T, Yoshida T. Ishikawa T, et al. Among authors: sano t. Exp Ther Med. 2015 Oct;10(4):1334-1338. doi: 10.3892/etm.2015.2674. Epub 2015 Aug 7. Exp Ther Med. 2015. PMID: 26622488 Free PMC article.
Improved survival with double platinum therapy transcatheter arterial infusion using cisplatin and transcatheter arterial chemoembolization using miriplatin for BCLC-B hepatocellular carcinoma.
Ishikawa T, Abe S, Watanabe T, Nozawa Y, Sano T, Iwanaga A, Seki K, Honma T, Yoshida T. Ishikawa T, et al. Among authors: sano t. Mol Clin Oncol. 2016 Nov;5(5):511-516. doi: 10.3892/mco.2016.998. Epub 2016 Aug 22. Mol Clin Oncol. 2016. PMID: 27882236 Free PMC article.
Successful Ombitasvir/Paritaprevir/Ritonavir Plus Ribavirin Retreatment for a Chronic Hepatitis C Genotype 2a Patient Who Relapsed after Sofosbuvir Plus Ribavirin Treatment.
Ishikawa T, Imai M, Owaki T, Sato H, Nozawa Y, Sano T, Iwanaga A, Seki K, Honma T, Yoshida T. Ishikawa T, et al. Among authors: sano t. Intern Med. 2018 Oct 1;57(19):2843-2845. doi: 10.2169/internalmedicine.0621-17. Epub 2018 May 18. Intern Med. 2018. PMID: 29780129 Free PMC article.
2,972 results